- Sunitinib - new clinical studies2007 | Publication without faculty affiliation
- Pazopanib vs. sunitinib in terms of patient preference - results of the PISCES study2012 | Second Faculty of Medicine
- Treatment with sunitinib in patient after right nefrectomy with metastatic affection of contralateral kidney2012 | Faculty of Medicine in Pilsen
- Survival of patients as a function of MSKCC scores for sunitinib treatment in the 1st mRCC treatment line2019 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Treatment of generalized renal cell carcinoma with sunitinib2010 | First Faculty of Medicine
- Sunitinib in the treatment of kidney cancer2007 | First Faculty of Medicine
- Radiological regression of metastatic renal carcinoma after biological treatment with Sunitinib - case report and literature review2020 | Faculty of Medicine in Hradec Králové
- New options for biologically targeted therapy of advanced non-small-cell lung cancer - sunitinib and sorasfenib2010 | Central Library of Charles University
- Alternativní dávkování sunitinibu v režimu 2 + 12017 | First Faculty of Medicine
- Sunitib in adjuvant treatment for renal cell carcinoma2017 | Publication without faculty affiliation
- Pilot study on microRNAs as biomarkers of response to sunitinib treatment in patients with metastatic renal cell carcinoma2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Combination avelumab-axitinib in metastatic renal cell carcinoma treatment2020 | First Faculty of Medicine
- Integration of surgery and molecular targeted therapy in advanced renal cell carcinoma2011 | Second Faculty of Medicine
- MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients2019 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Pacientka s pokročilým gastrointestinálním stromálním nádorem léčeným sunitinibem2018 | Publication without faculty affiliation
- Gastrointestinal stromal tumour: advances in treatment2020 | Publication without faculty affiliation
- Treatment of gastrointestinal stromal tumour2016 | Publication without faculty affiliation
- Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib2021 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency2015 | First Faculty of Medicine
- Gastrointestinal stromal tumour - the basic algorithm of diagnosis and treatment2014 | Second Faculty of Medicine
- Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma-data from the Czech registry2012 | First Faculty of Medicine
- Cabozantinib treatment - case report2020 | First Faculty of Medicine
- Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines2014 | First Faculty of Medicine, Second Faculty of Medicine
- Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma2012 | First Faculty of Medicine
- Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study2023 | First Faculty of Medicine
- A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma2012 | First Faculty of Medicine
- New perspectives of the systemic treatment for renal cancer2008 | First Faculty of Medicine
- Candidate MicroRNA biomarkers of therapeutic response to sunitinib in metastatic renal cell carcinoma: A validation study in patients with extremely good and poor response2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Renal cell carcinoma 20152015 | First Faculty of Medicine
- Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study2012 | First Faculty of Medicine